Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration
Anna Dittrich(Sahlgrenska University Hospital), Silke Kern(University of Gothenburg), Joel Simrén(University of Gothenburg), Kaj Blennow(Sahlgrenska University Hospital), Tobias Skillbäck(Sahlgrenska University Hospital), Alejandra Machado(Sahlgrenska University Hospital), Anna Zettergren(University of Gothenburg), Ingmar Skoog(Sahlgrenska University Hospital), Michael Schöll(Wallenberg Wood Science Center), Eric Westman(Wellcome Centre for Human Neuroimaging), Sara Shams(Karolinska University Hospital), Henrik Zetterberg(University of Wisconsin System), Nicholas J. Ashton(King's College London)
Cited by 74
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k